Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease?

被引:37
作者
Stone, DL
van Diggelen, OP
de Klerk, JBC
Gaillard, JLJ
Niermeijer, MF
Willemsen, R
Tayebi, N
Sidransky, E
机构
[1] NIMH, Clin Neurosci Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA
[2] Erasmus Univ, Univ Hosp, Dept Clin Genet, Rotterdam, Netherlands
[3] Erasmus Univ, Univ Hosp, Dept Pediat, Rotterdam, Netherlands
[4] St Clara Hosp, Dept Clin Pathol, Rotterdam, Netherlands
关键词
Gaucher disease; lysosomal storage disorder; hydrops fetalis; collodion baby; mutation analysis;
D O I
10.1038/sj.ejhg.5200315
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In recent years there has been increased recognition of a severe perinatal lethal form of Gaucher disease, the inherited deficiency of lysosomal glucocerebrosidase. We previously reported a case of severe type 2 Gaucher disease which was seen in a medical center in Rotterdam and now present three new cases fi om two other families seen at the same center. Mutational analyses of these cases revealed two novel mutations, H311R and V398F, located in exons 8 and 9, respectively. The identification of four cases of lethal type 2 Gaucher disease in a single center seems to be a function of increased awareness of this phenotype, rather than of geographic clustering. The actual incidence of lethal type 2 Gaucher disease may be underestimated, as many cases may have been misclassified as collodion babies or hydrops of unknown cause.
引用
收藏
页码:505 / 509
页数:5
相关论文
共 50 条
  • [31] Prevalence of autoantibodies in the course of Gaucher disease type 1: A multicenter study comparing Gaucher disease patients to healthy subjects
    Serratrice, Christine
    Bensalah, Nesma
    Penaranda, Guillaume
    Bardin, Nathalie
    Belmatoug, Nadia
    Masseau, Agathe
    Rose, Christian
    Lidove, Olivier
    Camou, Fabrice
    Maillot, Francois
    Leguy, Vanessa
    Magy-Bertrand, Nadine
    Marie, Isabelle
    Cherin, Patrick
    Bengherbia, Monia
    Carballo, Sebastian
    Boucraut, Jose
    Serratrice, Jacques
    Berger, Marc
    Verrot, Denis
    JOINT BONE SPINE, 2018, 85 (01) : 65 - 71
  • [32] Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease
    Biegstraaten, M.
    Cox, T. M.
    Belmatoug, N.
    Berger, M. G.
    Collin-Histed, T.
    Vom Dahl, S.
    Di Rocco, M.
    Fraga, C.
    Giona, F.
    Giraldo, P.
    Hasanhodzic, M.
    Hughes, D. A.
    Iversen, P. O.
    Kiewiet, A. I.
    Lukina, E.
    Machaczka, M.
    Marinakis, T.
    Mengel, E.
    Pastores, G. M.
    Ploeckinger, U.
    Rosenbaum, H.
    Serratrice, C.
    Symeonidis, A.
    Szer, J.
    Timmerman, J.
    Tylki-Szymanska, A.
    Hubshman, M. Weisz
    Zafeiriou, D. I.
    Zimran, A. a
    Hollak, C. E. M.
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 : 203 - 208
  • [33] Gaucher's disease type I: a disease masked by the presence of abnormal laboratory tests common to primary liver disease
    Saadi, Tarek
    Rosenbaum, Hana
    Veitsman, Ella
    Baruch, Yaacov
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (08) : 1019 - 1021
  • [34] Skin ultrastructural findings in type 2 Gaucher disease: Diagnostic implications
    Chan, Aegean
    Holleran, Walter M.
    Ferguson, Tajh
    Crumrine, Debra
    Goker-Alpan, Ozlem
    Schiffmann, Raphael
    Tayebi, Nahid
    Ginns, Edward I.
    Elias, Peter M.
    Sidransky, Ellen
    MOLECULAR GENETICS AND METABOLISM, 2011, 104 (04) : 631 - 636
  • [35] Type 2 Gaucher disease occurs in Ashkenazi Jews but is surprisingly rare
    Aviner, Shraga
    Garty, Ben-Zion
    Rachmel, Avinoam
    Baris, Hagit N.
    Sidransky, Ellen
    Shuffer, Avinoam
    Attias, Joseph
    Yaniv, Yisaac
    Cohen, Ian J.
    BLOOD CELLS MOLECULES AND DISEASES, 2009, 43 (03) : 294 - 297
  • [36] Enhanced calcium release in the acute neuronopathic form of Gaucher disease
    Pelled, D
    Trajkovic-Bodennec, S
    Lloyd-Evans, E
    Sidransky, E
    Schiffmann, R
    Futerman, AH
    NEUROBIOLOGY OF DISEASE, 2005, 18 (01) : 83 - 88
  • [37] Management of Bone Disease in Gaucher Disease Type 1: Clinical Practice
    Giuffrida, Gaetano
    Cappellini, Maria Domenica
    Carubbi, Francesca
    Di Rocco, Maja
    Iolascon, Giovanni
    ADVANCES IN THERAPY, 2014, 31 (12) : 1197 - 1212
  • [38] Pathological fracture and pyogenic osteomyelitis in a patient with type 2 Gaucher disease
    Hayashi, Anri
    Kawakita, Rie
    Kumada, Tomohiro
    Nozaki, Fumihito
    Hiejima, Ikuko
    Miyajima, Tomoko
    Kusunoki, Takashi
    Fujii, Tatsuya
    BRAIN & DEVELOPMENT, 2014, 36 (09) : 830 - 833
  • [39] Coagulation abnormalities in type 1 Gaucher disease in children
    Deghady, Akram
    Marzouk, Iman
    El-Shayeb, Ayman
    Wali, Yasseer
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2006, 23 (05) : 411 - 417
  • [40] Subarachnoid anesthesia in a patient with type I Gaucher disease
    Collada, JCG
    Marín, RM
    Martínez, AIG
    Serrano, EMM
    López, JFP
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2003, 47 (01) : 106 - 109